Assistant Professor of Surgery Harvard Medical School, Chief of Surgical Oncology VA Boston HCS
General Surgery
Dr. Jason S. Gold, MD
|
|
Give Review
Jason S. Gold, MD practices General Surgery. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He received awards:"ASCO Foundation Merit Award" and "Fellow (FACS)". Jason Gold is a published MD as well. He has 36 publications published. The latest was: Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue. Jason Gold accepts Medicare.
Publications
- Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous Intestinal tumorigenesis.
- Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
- Radiation therapy for unresectable pancreatic adenocarcinoma: population-based trends in utilization and survival rates in the United States.
- Population-Based Outcome of Stage IA-IIA Resected Gastric Adenocarcinoma: Who Should Get Adjuvant Treatment?
- Tumor Size and Depth Predict Rate of Lymph Node Metastasis in Colon Carcinoids and Can Be Used to Select Patients for Endoscopic Resection.
- Pancreatic acinar-like adenocarcinoma of the proximal Stomach invading the esophagus.
- ABCB5 identifies a therapy-refractory tumor cell population in coloRectal cancer patients.
- Tumor Size and Depth Predict Rate of Lymph Node Metastasis and Utilization of Lymph Node Sampling in Surgically Managed Gastric Carcinoids.
- Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastroIntestinal stromal tumor (GIST).
- Increased use of parenchymal-sparing surgery for bilateral liver metastases from coloRectal cancer is associated with improved mortality without change in oncologic ou...
- Utility of a prognostic nomogram designed for gastric Cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
- Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy.
- Neoadjuvant therapy for gastroIntestinal stromal tumor (GIST): racing against resistance.
- Outcome of patients with known metastatic gastric Cancer undergoing resection with therapeutic intent.
- Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
- Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
- Combined surgical and molecular therapy: the gastroIntestinal stromal tumor model.
- Partial median sternotomy: an attractive approach to mediastinal parathyroid disease.
- Autoimmunity and tumor immunity induced by immune responses to mutations in self.
- Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy.
- A single heteroclitic epitope determines Cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
- Clinicopathologic correlates of solitary fibrous tumors.
- Strategies to overcome immune ignorance and tolerance.
- Xenogeneic DNA immunization in melanoma models for minimal residual disease.
- The role of lipopolysaccharide in T-cell responses following DNA vaccination.
- Radical resection for T1b gallbladder cancer: a decision Analysis.
- Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastroIntestinal stromal tumour...
- Clinicopathologic Analysis of patients with adult rhabdomyosarcoma.
- Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status.
- Immunity against Cancer: lessons learned from melanoma.
- Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.
- Phase II trial of neoadjuvant temozolomide in resectable melanoma patients.
- Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.
- Loss of p120ctn in human coloRectal cancer predicts metastasis and poor survival.
- CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis.
Schools
Yale University
Yale New Haven Hospital
Memorial Sloan Kettering Cancer Center
Procedures Preformed
- Colectomy
- Enterostomy (Laparoscopic or Open)
- Hepatectomy
- Tracheal Surgery
Conditions Treated
- Anal and Rectal Cancer
- AnoRectal Abscess
- Cholecystitis and Gallstones
- ColoRectal Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- ASCO Foundation Merit Award
- Fellow (FACS)
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine -
Dartmouth College
Helpful Reviews
Similar Doctors
|
|
Dr. Charles J. Siegert, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grant V. Rodkey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Raffetto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Naren Gupta, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erica A. Brotschi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamal M. Itani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivian M. Sanchez, MD
This Doctor is OpenDoctor Recommended.
|